healthday5m
COVID-19 Infection Not Linked to Changes in MS Symptom Severity
COVID-19 infection is not associated with immediate changes in multiple sclerosis (MS) symptom severity or disabilit ...
healthday9m
Multimorbidity Tied to Accelerated Kidney Function Decline in Older Adults
Multimorbidity is strongly associated with accelerated kidney function decline in older age, according to a study pu ...
healthday12m
Prevalence of Post-COVID-19 Condition in Adults 8.4 Percent in 2023
The prevalence of post-COVID-19 condition (PCC) was 8.4 percent among U.S. adults in 2023, according to a research l ...
healthday26m
Neurological Outcomes Worsen With Gestational HTN, Preeclampsia, Eclampsia
Gestational hypertension, preeclampsia, and eclampsia are associated with an increased risk for neurological outcome ...
healthday32m
Brief Outpatient Rehab Program Beneficial for Post-COVID-19 Condition
THURSDAY, Dec. 26, 2024 (HealthDay News) -- A brief outpatient rehabilitation program with a cognitive and behavioral ...
healthday18m
Study IDs Specific Anaphylactic Triggers Linked to Symptoms, Treatment
Specific anaphylactic triggers are associated with symptoms and treatments, according to a study published online No ...
healthday21m
Prevalence of Cirrhosis Higher for Trans- Versus Cisgender Adults
Trans- versus cisgender adults have an increased prevalence of cirrhosis but similar five-year survival, according t ...
healthday15m
Atogepant Superior for Efficacy, Functional Measures in Migraine
THURSDAY, Dec. 26, 2024 (HealthDay News) -- For adults with migraine, atogepant 60 mg once daily was superior to placebo for efficacy and functional measures of treatment across three trials, ...